ESSA Pharma Inc.·4

Mar 28, 12:33 PM ET

Glickman Richard M 4

4 · ESSA Pharma Inc. · Filed Mar 28, 2024

Insider Transaction Report

Form 4
Period: 2024-03-25
Transactions
  • Award

    Options

    2024-03-25+70,00070,000 total
    Exercise: $9.04From: 2025-03-25Exp: 2034-03-25Common Shares (70,000 underlying)

Documents

1 file
  • 4
    form4.xmlPrimary